Parkinson Disease | Parkinsonian Disorders
Item
all patients must have idiopathic pd diagnosed as parkinsonism according to the uk brain bank criteria, and pd considered the likeliest underlying cause according to the treating physician. other inclusion criteria include:
boolean
C0030567 (UMLS CUI [1])
C0242422 (UMLS CUI [2])
Parkinson Disease Disease length
Item
1. pd diagnosis: between 6 months and 6 years
boolean
C0030567 (UMLS CUI [1,1])
C0872146 (UMLS CUI [1,2])
Hoehn and Yahr Stage
Item
2. hoehn and yahr stage i-iii
boolean
C3639483 (UMLS CUI [1])
Age
Item
3. age at least 45 and less than 75 (to optimize survival over the 5-year trial).
boolean
C0001779 (UMLS CUI [1])
Therapy Symptomatic Parkinson Disease | Dose Stable
Item
4. receiving symptomatic therapy for pd for at least 6 months. dose must have been stable over the previous 3 months.
boolean
C0087111 (UMLS CUI [1,1])
C0231220 (UMLS CUI [1,2])
C0030567 (UMLS CUI [1,3])
C0178602 (UMLS CUI [2,1])
C0205360 (UMLS CUI [2,2])
Caffeine intake U/day | Adenosine receptor antagonist | Caffeine intake Questionnaire
Item
1. caffeine intake >150 mg per day (i.e. more than one cup of filtered coffee per day) or prescribed adenosine antagonists - caffeine intake will be measured by a standardized intake questionnaire. intake will be converted into estimated caffeine mg dose by standard caffeine-content charts.
boolean
C4062719 (UMLS CUI [1,1])
C0456683 (UMLS CUI [1,2])
C0815050 (UMLS CUI [2])
C4062719 (UMLS CUI [3,1])
C0034394 (UMLS CUI [3,2])
Peptic Ulcer | Gastroesophageal reflux disease Symptomatic
Item
2. active peptic ulcer disease, or symptomatic gastroesophageal reflux disease.
boolean
C0030920 (UMLS CUI [1])
C0017168 (UMLS CUI [2,1])
C0231220 (UMLS CUI [2,2])
Supraventricular arrhythmia cardiac | Atrial Fibrillation | Atrial Flutter
Item
3. supraventricular cardiac arrhythmia (such as atrial fibrillation or atrial flutter) -
boolean
C0428974 (UMLS CUI [1,1])
C0018787 (UMLS CUI [1,2])
C0004238 (UMLS CUI [2])
C0004239 (UMLS CUI [3])
Electrocardiography out ruling Supraventricular tachycardia
Item
electrocardiogram will be measured at baseline to rule out supraventricular tachycardia.
boolean
C1623258 (UMLS CUI [1,1])
C0332196 (UMLS CUI [1,2])
C0039240 (UMLS CUI [1,3])
Uncontrolled hypertension | Systolic Pressure | Diastolic blood pressure
Item
4. uncontrolled hypertension - systolic bp >170 or diastolic bp >110 on two readings.
boolean
C1868885 (UMLS CUI [1])
C0871470 (UMLS CUI [2])
C0428883 (UMLS CUI [3])
Premenopausal state Contraceptive methods Absent
Item
5. pre-menopausal women who are not using effective methods of birth control
boolean
C0232969 (UMLS CUI [1,1])
C0700589 (UMLS CUI [1,2])
C0332197 (UMLS CUI [1,3])
Impaired cognition MoCA
Item
6. cognitive impairment, defined as moca <23/30.
boolean
C0338656 (UMLS CUI [1,1])
C3496286 (UMLS CUI [1,2])
Moderate depression Beck depression inventory | Severe depression Beck depression inventory
Item
7. moderate-severe depression, as defined by a beck depression inventory score of >19.
boolean
C0588007 (UMLS CUI [1,1])
C0451022 (UMLS CUI [1,2])
C0588008 (UMLS CUI [2,1])
C0451022 (UMLS CUI [2,2])
Antiparkinson Agents Change | Antiparkinson Agents Change Anticipated
Item
8. changes to antiparkinsonian medication in the last 3 months, or changes to antiparkinsonian medication are anticipated during the next six months.
boolean
C0003405 (UMLS CUI [1,1])
C0392747 (UMLS CUI [1,2])
C0003405 (UMLS CUI [2,1])
C0392747 (UMLS CUI [2,2])
C3840775 (UMLS CUI [2,3])
Lithium | Clozapine | Pharmacokinetic interaction
Item
9. current use of lithium or clozapine (pharmacokinetic interactions).
boolean
C0023870 (UMLS CUI [1])
C0009079 (UMLS CUI [2])
C1868980 (UMLS CUI [3])